Gene Query: CLDN6

Dataset Description Geneva Score
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 87.96
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 84.67
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 80.35
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 79.9
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 64.73
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 58.31
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 56.88
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 55.69
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 53.2
RNA-Seq from early time points in the kidney differentiation protocol 52.0
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 50.4
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 49.51
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 47.81
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 47.81
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 46.67
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 46.07
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 45.11
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 45.11
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 45.07
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 43.78
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 43.14
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 42.8
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 42.7
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 42.59
Differentially expressed vascular development genes for iPSC-ECs from CDI 42.5
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 40.73
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 40.71
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 39.38
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 39.12
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 38.98
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 38.76
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 38.75
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 37.39
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 34.97
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 34.71
Transcriptome analysis of H9 hESC derived cerebral organoids 34.67
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 34.45
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 34.08
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 32.98
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 32.67
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 32.67
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 32.57
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 32.54
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 32.13
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 32.01
Examining serotonergic neuron differentiation from human iPSCs 32.0
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 31.63
High-efficiency RNA-based reprogramming of human primary fibroblasts 31.27
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 31.0
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 30.61
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 30.01
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 29.66
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 29.66
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 29.28
Cerebellar differentiation in Ataxia-Telangiectasia 29.23
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 29.16
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 28.98
Total RNA sequencing of WT intestinal orgaonids. 27.37
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 26.74
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 26.74
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 26.6
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 26.55
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 26.54
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 25.76
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 25.76
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 25.62
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 25.51
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 25.5
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 25.39
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 25.32
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 25.32
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 24.29
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 23.84
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 23.84
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 23.68
MEIS1 regulates hematopoiesis in hPSCs 23.59
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 22.16
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 22.16
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 21.84
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 21.84
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 21.34
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 21.3
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 21.23
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 21.12
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 21.0
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 20.75
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 20.45
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 20.36
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 20.17
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 20.16
Gene profiling of human adult and pediatric liver cancer cells 20.15
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 19.87
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 19.87
19.87
Postnatal lipids drive hepatocyte maturation 19.44
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 19.04
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 18.85
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 18.33
Next Generation Sequencing of human SMA and healthy control Motor Neurons 17.92
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 17.76
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 17.37
Expression profiles of the four human major ectodermal lineages 17.22
Epigenome regulation during epidermal lineage commitment 17.06
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 15.82
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 15.79
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 15.79
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 15.66
Epigenome regulation during epidermal lineage commitment [RNA-seq] 15.35
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 15.11
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 15.02
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 14.91
FGF2 regulation of gene expression in stable inducible Neurons 14.87
Engineering Patient-Specific Tissue Implants 14.71
Identification of a LIF-responsive replication-competent human β cell 14.63
Dynamic reorganization of nuclear architecture during human cardiogenesis 14.52
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 14.52
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 14.41
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 13.88
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 13.82
BI Human Reference Epigenome Mapping Project 13.81
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 13.11
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 13.01
Tyrosine Kinase Inhibitor Cardiotoxicity 13.01
Transcriptome analysis of virus infected tissues 12.95
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 12.85
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 12.85
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 12.72
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 12.64
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 12.57
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 12.47
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 12.47
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 12.44
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 12.44
iPSC-Derived Cholangiocytes 12.06
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 11.98
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 11.95
High-throughput sequencing of pluripotent cells 11.74
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 11.69
RNA sequencing analysis of human embryonic stem cells and axial progenitors 11.67
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 11.57
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 11.55
scRNASeq analysis of cycling cardiomyocytes 11.52
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 11.51
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 11.17
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 11.09
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 11.02
Gene expression patterns define the hepatocyte-like cells derived by different strategies 11.02
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 10.97
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 10.97
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 10.81
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 10.71
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 10.69
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 10.69
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 10.58
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 10.5
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 9.97
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 9.69
Gene expression analysis of dengue-infected cells 9.39
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 9.31
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 9.28
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 9.26
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 9.23
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 9.07
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 8.98
RNA-seq analysis of gene expression patterns during hESC neural differentiation 8.9
hESC neural differentiation 8.9
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 8.53
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 8.35
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 8.34
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 8.07
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 8.04
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 7.95
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 7.48
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 7.3
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 7.3
The transcriptome and chromatin accessbility landscape of mammalian germline 7.3
CHCHD2 gene KO effect in iPSC drived motor neurons 7.27
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 7.18
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.18
Dissecting neural differentiation regulatory networks through epigenetic footprinting 7.12
Derivation and differentiation of haploid human embryonic stem cells 7.06
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 6.95
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 6.87
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.46
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 6.44
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 6.43
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 6.16
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 6.01
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 5.95
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 5.94
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 5.75
Hepatitis C virus functionally sequesters miR-122 5.73
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 5.73
RNA-seq analysis of RALD iPSCs after in vitro differentiation 5.65
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 5.51
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 5.36
Depicting early human development and germ cell origin with porcine embryos 5.21
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 5.08
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.02
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.02
CHCHD10 gene KO effect in iPSC drived motor neurons 4.94
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.89
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 4.82
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.79
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 4.7
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 4.63
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 4.5
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 4.49
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 4.41
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 4.41
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 4.41
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 4.37
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 4.37
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.33
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 4.28
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 4.21
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.11
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 4.04
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 3.99
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 3.99
Microglia innatly develop within cerebral organoids 3.93
Transciptomic profiling of human fetal lung samples 3.82
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 3.81
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.8
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 3.77
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 3.77
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 3.75
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 3.7
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 3.69
In vitro modeling of human germ cell development using pluripotent stem cells 3.57
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 3.57
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 3.53
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 3.53
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 3.53
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 3.42
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 3.4
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 3.4
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.33
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.28
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 3.16
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 3.05
Transcriptome of EBV-infected gastric cancer cell lines 3.03
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 3.02
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.89
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 2.72
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 2.71
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 2.64
Total RNA sequencing of APC mutant and wt colonic organoids 2.63
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.63
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 2.5
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 2.45
Glucose inhibits cardiac maturation through nucleotide biosynthesis 2.45
Global analyses of the effect of different cellular contexts on microRNA targeting 2.4
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 2.4
Subtle asymmetry of gene expression in embryonic and foetal human brains 2.39
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 2.36
Disruption of GRIN2B impairs differentiation in human neurons 2.33
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.29
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 2.27
Iron response of HepG2 cells 2.17
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.15
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 2.15
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 2.14
Lineage specific differentiation is influenced by state of human pluripotency 2.14
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 2.09
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.06
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 2.05
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 2.05
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.04
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 1.97
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 1.97
RNA Sequencing of Human iPS derived Cardiomyocytes 1.95
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 1.92
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.89
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 1.89
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 1.88
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 1.88
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.82
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.82
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 1.82
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 1.81
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 1.79
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 1.77
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.75
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 1.75
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 1.73
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 1.72
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 1.72
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 1.69
RNA seq analysis of human Fetal and adult derived Enterospheres 1.66
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.65
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.64
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.59
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 1.52
Global transcriptome analysis of HAP1 cells 1.5
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.47
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.47
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 1.47
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 1.47
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.45
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 1.43
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.43
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.42
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 1.41
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.41
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 1.4
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 1.4
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.39
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.37
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.32
RNA-Sequencing of HepG2 cells treated with TGFBeta 1.31
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.27
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 1.25
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 1.22
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 1.17
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 1.15
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 1.14
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 1.14
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 1.14
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 1.11
Direct Isolation and Characterization of Human Nephron Progenitors. 1.11
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 1.1
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 1.08
Mechanistic Model-Guided Study of Embryonic Morphogenesis 1.05
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 1.03
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 1.03
AMPK signaling for naïve pluripotency [Hs] 1.03
AMPK signaling for naïve pluripotency 1.03
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.0
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 0.99
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.98
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.97
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 0.95
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.9
Transcriptional landscape changes during human embryonic stem cell derivation 0.89
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 0.88
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.88
Ectoderm specification of H1 human embryonic stem cells 0.88
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.88
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 0.85
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.83
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.82
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 0.82
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.81
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 0.76
Hepatocyte maturation 0.75
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 0.74
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 0.74
mRNA-Seq profiling of human developing kidney 0.7
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 0.7
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 0.7
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 0.69
Global expression profiles in cardiac progenitor cells generated by ISX-9 0.69
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 0.67
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 0.67
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 0.66
RNA-seq analysis of the human fetal kidney. 0.65
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 0.65
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 0.65
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 0.65
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 0.63
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 0.63
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.62
High level DNA repair gene expression in human ES cells 0.6
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 0.59
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 0.59
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 0.57
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 0.56
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 0.56
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 0.56
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 0.56
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 0.56
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 0.54
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 0.53
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.52
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 0.51
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 0.51
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 0.51
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.5
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.5
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 0.49
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 0.48
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.48
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.47
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 0.45
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 0.45
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.45
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.44
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.44
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.43
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 0.42
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.42
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 0.41
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.41
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.4
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.4
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.4
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 0.39
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 0.36
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 0.36
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 0.36
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.36
RNA-seq of YB5 cells treated with Proscillaridin A 0.36
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.35
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.35
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 0.34
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 0.34
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 0.33
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.33
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.32
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.32
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.31
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 0.3
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 0.29
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.29
BET bromodomain inhibition 0.27
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.27
CDK12 mediated transcriptional regulation in U2OS cells 0.27
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.27
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.26
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.26
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 0.26
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 0.26
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.25
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.25
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 0.25
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 0.25
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.25
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 0.24
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 0.23
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.23
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.23
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.22
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 0.21
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 0.21
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 0.21
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.19
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.19
Primary human trophoblast from term placenta 0.18
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.18
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.18
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.18
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.18
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 0.17
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 0.17
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.16
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.16
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.16
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.16
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.16
HNF1A deficiency impairs β-cell fate, granule maturation and function 0.16
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.15
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 0.15
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.15
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 0.14
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 0.14
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.14
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.14
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.13
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 0.13
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.12
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.12
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.12
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.11
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 0.1
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.09
ML29755 RNA-seq data 0.09
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 0.09
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.09
Molecular analysis of renal cell carcinoma with unclassfied histology 0.09
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 0.08
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.06
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.05
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.05
RNA-Seq in PWS iPSC-derived neurons 0.05
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 0.05
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.04
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 0.04
Gene expression profile of human iPSC-derived nephron progenitor cells 0.04
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.04
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.04
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.04
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.04
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 0.03
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.03
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.03
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 0.03
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.02
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.02
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.02
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.02
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.02
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.02
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.02
Hepatic transcriptome of pediatric hepatoblastoma. 0.01
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.01
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.01
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.01
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.01
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation